-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b7512fbd-a3c1-4048-ab00-eddb8590ba6a&Preview=1 -
Date
11/17/2008 -
Company Name
Eureka Therapeutics -
Mailing Address
5858 Horton Street Emeryville, CA 94608 -
Company Description
Eureka Therapeutics, Inc. is a privately-owned, venture capital-funded biotechnology company headquartered in Emeryville, California. Eureka provides a range of services and products to partner companies pursuing therapeutic antibody treatments for disease.Our primary technology involves the enhancement of the ADCC activity of human (or humanized) antibodies to improve their clinical efficacy. Currently, Eureka has one US research facility dedicated to technology innovation and service provision, and one Chinese subsidiary in Beijing for carrying.
-
Website
http://www.eurekainc.com -
Transaction Type
Venture Equity -
Transaction Amount
$6,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed